ArticleHemaSphere2022

Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma.

Roch Houot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.